Irina B. Torres

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative GN in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Natural History and Progression of Recurrent C3 Glomerulopathy and Primary Immune-Complex Membranoproliferative Glomerulonephritis in Kidney Transplantation.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 16, 2026

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Published: October 30, 2025

Exhausted/senescent CD4+ T cells as predictors of vaccine failure and severe coronavirus disease 2019 in solid organ transplant recipients.

Exhausted/senescent CD4+ T cells as predictors of vaccine failure and severe coronavirus disease 2019 in solid organ transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 12, 2025

On the relative relevance of donor-derived cell-free DNA and urinary chemokines as noninvasive biomarkers for the diagnosis of kidney allograft rejection.

On the relative relevance of donor-derived cell-free DNA and urinary chemokines as noninvasive biomarkers for the diagnosis of kidney allograft rejection.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 11, 2025

On the relative relevance of donor-derived cell-free DNA and urinary chemokines as non-invasive biomarkers for the diagnosis of kidney allograft rejection.

On the relative relevance of donor-derived cell-free DNA and urinary chemokines as non-invasive biomarkers for the diagnosis of kidney allograft rejection.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 11, 2025

Dual targeting of B cell compartments using belatacept and daratumumab in highly sensitized kidney transplant candidates: A mechanistic proof-of-concept desensitization trial.

Dual targeting of B cell compartments using belatacept and daratumumab in highly sensitized kidney transplant candidates: A mechanistic proof-of-concept desensitization trial.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 09, 2025

Estimating the Contribution of Renal Function to Endothelial Dysfunction and Subclinical Inflammation with a Two-Cohort Study: Living Kidney Donors and Their Transplant Recipients.

Estimating the Contribution of Renal Function to Endothelial Dysfunction and Subclinical Inflammation with a Two-Cohort Study: Living Kidney Donors and Their Transplant Recipients.

Journal: International journal of molecular sciences

Published: August 16, 2025

A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation.

A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation.

Journal: Kidney international reports

Published: April 12, 2025

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Eculizumab as rescue therapy for antibody-mediated rejection in a high-risk lung transplant recipient: A case report.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Published: March 13, 2025

Early Acute T Cell-Mediated Rejection and Kidney Allograft Outcomes.

Early Acute T Cell-Mediated Rejection and Kidney Allograft Outcomes.

Journal: Kidney international

Published: February 24, 2025

Development and validation of the Neuro-Score: a specific scale to detect and monitor cognitive impairment in kidney or liver transplant recipients.

Development and validation of the Neuro-Score: a specific scale to detect and monitor cognitive impairment in kidney or liver transplant recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: July 28, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026